Nicholas Company, Inc. Amgen Inc Transaction History

Nicholas Company, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $32.4 Million - $37.7 Million	-145,850 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $86,552 - $103,068	400 Added 0.28%	145,850 $33.5 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $10,559 - $11,742	-45 Reduced 0.03%	145,450 $37 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $13,668 - $18,127	75 Added 0.05%	145,495 $29.5 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $4,730 - $6,080	-25 Reduced 0.02%	145,420 $35.1 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1,667 - $1,954	-10 Reduced 0.01%	145,445 $26.8 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $6,330 - $7,135	35 Added 0.02%	145,455 $27.6 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $5,558 - $6,266	-30 Reduced 0.02%	145,420 $30.1 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $24.2 Million - $27.1 Million	145,450 New	145,450 $26.8 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Company, Inc. with notifications on news.